Notice of Results
April 20 2009 - 10:20AM
UK Regulatory
TIDMGWP
RNS Number : 8471Q
GW Pharmaceuticals PLC
20 April 2009
GW Pharmaceuticals plc
Notification of Results
Porton Down, UK, 20 April, 2009: GW Pharmaceuticals plc (AIM: GWP) will be
announcing its interim financial results for the six months ended 31 March 2009
on Wednesday 20 May 2009.
Enquiries:
+--------------------------------------+---------------------+
| Financial Dynamics | 020 7831 3113 |
+--------------------------------------+---------------------+
| Ben Atwell / John Dineen | |
+--------------------------------------+---------------------+
Notes to Editors
About GW Pharmaceuticals
GW was founded in 1998 and listed on the AIM, a market of the London Stock
Exchange in June 2001. Operating under license from the UK Home Office, the
company is developing cannabis-derived pharmaceutical products for patients with
multiple sclerosis, neuropathic pain, cancer pain, spinal cord injury,
rheumatoid arthritis, and other severe medical conditions.
GW has assembled a team of over 100 scientists with extensive experience in
developing both plant-based prescription pharmaceutical products and medicines
containing controlled substances. GW is dedicated to developing treatment
options that alleviate pain symptoms in patients who suffer from serious
ailments.
For further information, please visit the Company's website: www.gwpharm.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORZBLFLKZBLBBB
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024